Insider Trading & Ownership - SCHIMMEL PAUL

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SCHIMMEL PAUL
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-10
Purchase
2023-05-11
09:00 am
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
200,000$2.25$450,0001,001,056
(Indirect
Direct)
View
2021-09-20
Purchase
2021-09-22
8:19 pm
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
250,000$8$2,000,000795,056
(Indirect
Direct)
View
2021-05-18
Purchase
2021-05-20
08:55 am
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
50,000$3.98$199,000545,056
(Indirect
Direct)
View
2020-05-20
Sale
2020-05-22
8:13 pm
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
8,447$3.639$30,739495,056
(Indirect
Direct)
View
2020-02-10
Purchase
2020-02-11
11:58 am
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
254,000$4.25$1,079,500503,503
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-17
Option Award
2023-05-19
4:32 pm
N/A
2033-05-17
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
12,000$012,000
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:54 pm
N/A
N/A
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
6,000$0801,056
(Direct)
View
2022-04-26
Option Award
2022-04-28
7:53 pm
N/A
N/A
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
6,000$06,000
(Direct)
View
2021-09-20
Gift
2021-09-22
8:19 pm
N/A
N/A
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
250,000$0795,056
(Direct)
View
2021-04-28
Option Award
2021-04-29
8:13 pm
N/A
2031-04-28
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
1,428$01,428
(Direct)
View
2020-05-06
Option Award
2020-05-08
5:14 pm
N/A
2030-05-06
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
1,428$01,428
(Direct)
View
2019-10-04
Option Award
2019-10-04
8:11 pm
N/A
2029-10-03
Tocagen IncTOCASCHIMMEL PAUL
Director
7,500$07,500
(Direct)
View
2019-07-01
Option Award
2019-07-02
4:06 pm
2020-07-01
2029-06-30
ALNYLAM PHARMACEUTICALS INC.ALNYSCHIMMEL PAUL
Director
9,000$09,000
(Direct)
View
2019-05-29
Option Award
2019-05-31
4:22 pm
N/A
2029-05-28
Tocagen IncTOCASCHIMMEL PAUL
Director
20,000$020,000
(Direct)
View
2019-05-08
Option Award
2019-05-10
5:35 pm
N/A
2029-05-08
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
20,000$020,000
(Direct)
View
2019-04-12
Option Award
2019-04-16
4:31 pm
N/A
N/A
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
1,848,428$0.5413,492,984
(Indirect)
View